Patents by Inventor Barry Kiely

Barry Kiely has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
    Patent number: 11590179
    Abstract: Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: February 28, 2023
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Liam O'Mahony, David Groeger
  • Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
    Patent number: 11529381
    Abstract: An isolated strain of Bifidobacterium longum NCIMB 42020 is useful for the treatment of viral infections, especially viral respiratory infections such as influenza, rhinovirus and RSV. Bifidobacterium longum NCIMB 42020 is also useful for clearing secondary bacterial infections.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: December 20, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Liam O'Mahony, David Groeger
  • for treating obesity and associated metabolic disorders
    Patent number: 11490643
    Abstract: The strain Lactobacillus casei AH077 (NCIMB12019) produces a polysaccharide and increases energy excretion. The strain acts to block fat absorption and is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: November 8, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • Combination product for prophylaxis and treatment of irritable bowel syndrome
    Patent number: 11400123
    Abstract: A combination product comprising an isolated strain of Bifidobacterium NCIMB 41003 and another strain which does not adversely interact with Bifidobacterium NCIMB 41003 improves gastrointestinal symptoms associated with IBS and improves one or more of mood, stress, anxiety, sleep quality and depression associated with IBS.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: August 2, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, David Groeger
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20220169976
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 2, 2022
    Applicant: PRECISIONBIOTICS GROUP LIMITED
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Probiotic strain
    Patent number: 11225641
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: January 18, 2022
    Assignee: PrecisionBiotics Group Limited
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • for treating obesity and associated metabolic disorders
    Patent number: 10973862
    Abstract: Bifidobacterium longum AH1362 (NCIMB 41715) produces a polysaccharide and increases energy excretion. The strain is used in the prevention or treatment of obesity and obesity-related metabolic syndrome.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: April 13, 2021
    Assignee: PrecisionBiotics Group Limited
    Inventors: Barry Kiely, Eileen Frances Murphy, Selena Healy
  • BIFIDOBACTERIUM LONGUM
    Publication number: 20200115685
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: November 8, 2019
    Publication date: April 16, 2020
    Applicant: Alimentary Health Ltd.
    Inventors: Jose Carlos GARCIA-GARCIA, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Probiotic bifidobacterium strain
    Patent number: 10597739
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: March 24, 2020
    Assignee: PrecisionBiotics Group Limited
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Patent number: 10519430
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: December 31, 2019
    Assignee: Alimentary Health Ltd.
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Bifidobacterium longum
    Publication number: 20190153408
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: February 4, 2019
    Publication date: May 23, 2019
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Patent number: 10233433
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: March 19, 2019
    Assignees: Alimentary Health Ltd., The Procter & Gamble Company
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Probiotic bifidobacterium strain
    Patent number: 10144978
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: December 4, 2018
    Assignee: Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • PROBIOTIC BIFIDOBACTERIUM STRAIN
    Publication number: 20180202010
    Abstract: Probiotic Bifidobacterium strain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: July 19, 2018
    Applicant: Alimentary Health Ltd
    Inventors: Liam O'MAHONY, Barry Kiely, John Francis Cryan, Timothy Dinan, Eileen Frances Murphy
  • Bifidobacterium longum
    Publication number: 20170058270
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: August 26, 2016
    Publication date: March 2, 2017
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • strain
    Patent number: 9259019
    Abstract: Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: February 16, 2016
    Assignees: Mars, Incorporated, Alimentary Health Ltd.
    Inventors: Liam O'Mahony, Barry Kiely
  • PROBIOTIC BIFIDOBACTERIUM STRAINS
    Publication number: 20140328879
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Application
    Filed: March 18, 2014
    Publication date: November 6, 2014
    Applicant: ALIMENTARY HEALTH LIMITED
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Probiotic strains
    Patent number: 8709398
    Abstract: Probiotic Bifidobacterium strain AH1205 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity such as undesirable gastrointestinal inflammatory activity for example inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: April 29, 2014
    Assignee: Alimentary Health Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • Probiotic bifidobacterium strains
    Patent number: 8557233
    Abstract: Bifidobacterium strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease.
    Type: Grant
    Filed: March 28, 2008
    Date of Patent: October 15, 2013
    Assignee: Alimentary Heath Limited
    Inventors: John MacSharry, Liam O'Mahony, David O'Sullivan, Barry Kiely
  • BIFIDOBACTERIUM STRAIN
    Publication number: 20130004540
    Abstract: Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.
    Type: Application
    Filed: May 10, 2012
    Publication date: January 3, 2013
    Inventors: Liam O'mahony, Barry Kiely